Physician profile
Michael Subik
NPI 1003813551
$528,599.40
in general payments reported to CMS, 2019-2025
29 companies · $82K in 2025
The $82K reported for 2025 was more than what 99% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $92K · 2020: $100K · 2021: $88K · 2022: $84K · 2023: $53K · 2024: $29K · 2025: $82K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $140K · Travel and Lodging: $17K · Food and Beverage: $7,535.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $139,701.20 |
| Travel and Lodging | $17,085.96 |
| Food and Beverage | $7,535.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $398,263.78 | 2019-2025 | Hoffmann, Salvation, Sonicanchor |
| Orthofix Medical, INC. | $93,701.60 | 2019-2025 | Truelok, Oscar Pro, Tl-Hex Truelok Hexapod System |
| Davol INC. | $20,876.89 | 2019-2025 | Channel Drain |
| Trice Medical, INC. | $13,268.62 | 2020-2022 | |
| Smith+Nephew, INC. | $396.33 | 2019-2024 | Collagenase Santyl |
| Integra Lifesciences Corporation | $332.97 | 2019-2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Misonix INC | $326.03 | 2019-2021 | |
| Kerecis Limited | $166.10 | 2023-2024 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Bone Support INC. | $156.27 | 2024 | Cerament G, Ceramentbone Void Filler |
| Medshape, INC. | $148.18 | 2025 | |
| Celularity INC. | $125.00 | 2019 | |
| Extremity Medical | $113.32 | 2019 | |
| Si-Bone, INC. | $104.92 | 2025 | |
| Acera Surgical, INC. | $83.60 | 2021-2023 | Restrata Wound Matrix |
| Novastep INC. | $80.57 | 2021 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acumed LLC | $79.50 | 2024 | Acumed, Osteomed |
| Boston Scientific Corporation | $63.14 | 2019 | |
| Cardiovascular Systems INC. | $47.68 | 2019 | |
| Reapplix INC. | $44.67 | 2025 | 3c Patch Kit - Box |
| Organogenesis INC. | $38.41 | 2022-2024 | |
| Treace Medical Concepts, INC. | $37.89 | 2022-2024 | |
| Zimmer Biomet Holdings, INC. | $29.87 | 2021 | |
| Sanara Medtech INC. | $27.82 | 2024 | Celleraterx |
| My01 INC. | $23.20 | 2022 | |
| Merck Sharp & Dohme LLC | $14.96 | 2019 | |
| Paratek Pharmaceuticals, INC. | $14.62 | 2025 | Nuzyra |
| Kowa Pharmaceuticals America, INC. | $13.08 | 2023 | Seglentis |
| Tenex Health INC. | $12.68 | 2020 | |
| Lifenet Health | $7.70 | 2025 | Theragenesis Wound Matrix |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Subik listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.